Evaluation of the clinical evolution of patients with Multidrug Resistant Tuberculosis

Detalhes bibliográficos
Autor(a) principal: Rocha, Paula Sousa da Silva
Data de Publicação: 2020
Outros Autores: Carvalho, Dayara de Nazaré Rosa de, Bendelaque, Dandara de Fátima Ribeiro, Soares, Felipe Costa, Costa, Rafael Everton Assunção Ribeiro da, Dergan, Marcela Raíssa Asevedo, Rodrigues, Rogéria de Sousa, Neves, Jucilene Luz, Pinheiro, Ana Carolina Marinho, Souza, Thais Neves de, Souza, Susi dos Santos Barreto de, Neves, Kathleen Heloisa Pinheiro Costa, Peixoto, Ivonete Vieira Pereira, Penela, Armando Sequeira, Andrade, Marcieni Ataíde, Silva, Marcos Valério Santos da
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/8615
Resumo: Objective: To assess the clinical evolution of patients with Multiple Drug-Resistant Tuberculosis treated in a referral center in the Amazon region, between the years 2010 to 2014. Methods: Cross-sectional, descriptive and quantitative approach research, through the collection of patient data attended at Hospital Universitário de Belém do Pará, between the years 2010 and 2014. Results: There was a predominance of males and a faixa age most affected was in the most productive phase (18 to 55 years old), secondary to teaching 94.1% were present in two cases, or time of diagnosis and initiation of treatment from 1 to 10 days appeared in the majority, how many years profile of drug resistance prevailing with rifampicin, isoniazid and streptomycin and most associated comorbidities foi or diabetes. Conclusion: There is a great complexity surrounding the aspects related to the treatment of Tuberculous Resistant to Multiple Medications, and that these factors contribute to the maintenance of two high teaching indices, as well as a scarcity of technologies such as rapid diagnosis of the teaching and availability of more alternatives of most effective treatment. The limiting factor of the investigation is due to the fact that it is a matter of medical records, there is no pattern of records in some, with little information.
id UNIFEI_a9bf9ff2b5780e1ed40080b50d9c7af3
oai_identifier_str oai:ojs.pkp.sfu.ca:article/8615
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Evaluation of the clinical evolution of patients with Multidrug Resistant TuberculosisEvaluación de la evolución clínica de los pacientes con Tuberculosis MultirresistenteAvaliação da evolução clínica de pacientes portadores de Tuberculose Resistente a Múltiplos MedicamentosMultidrug resistant tuberculosisPublic healthAmazon. Tuberculosis multirresistente resistenteSalud públicaAmazonas.Tuberculose resistente a múltiplos medicamentosSaúde públicaAmazônia.Objective: To assess the clinical evolution of patients with Multiple Drug-Resistant Tuberculosis treated in a referral center in the Amazon region, between the years 2010 to 2014. Methods: Cross-sectional, descriptive and quantitative approach research, through the collection of patient data attended at Hospital Universitário de Belém do Pará, between the years 2010 and 2014. Results: There was a predominance of males and a faixa age most affected was in the most productive phase (18 to 55 years old), secondary to teaching 94.1% were present in two cases, or time of diagnosis and initiation of treatment from 1 to 10 days appeared in the majority, how many years profile of drug resistance prevailing with rifampicin, isoniazid and streptomycin and most associated comorbidities foi or diabetes. Conclusion: There is a great complexity surrounding the aspects related to the treatment of Tuberculous Resistant to Multiple Medications, and that these factors contribute to the maintenance of two high teaching indices, as well as a scarcity of technologies such as rapid diagnosis of the teaching and availability of more alternatives of most effective treatment. The limiting factor of the investigation is due to the fact that it is a matter of medical records, there is no pattern of records in some, with little information.Objetivo: Evaluar la evolución clínica de pacientes con Tuberculosis Resistente a Múltiples Fármacos atendidos en un centro de referencia de la Amazonía, entre los años 2010 a 2014. Métodos: Abordaje transversal, descriptivo y cuantitativo, mediante la recolección de datos de pacientes atendidos en el Hospital Universitário de Belém do Pará, entre 2010 y 2014. Resultados: Predominó el sexo masculino y el grupo de edad más afectado fue el de la fase más productiva (18 a 55 años), la forma secundaria de la enfermedad estuvo presente en el 94,1% de los casos, el tiempo del diagnóstico y el inicio del tratamiento de 1 a 10 días apareció en la mayoría, con respecto al perfil de farmacorresistencia que prevaleció fueron rifampicina, isoniazida y estreptomicina y las comorbilidades más asociadas fue la diabetes. Conclusión: Existe una gran complejidad que involucra aspectos relacionados con el tratamiento de la Tuberculosis Múltiple Resistente a Fármacos, y que estos factores contribuyen al mantenimiento de altas tasas de enfermedad, como la escasez de tecnologías como el diagnóstico rápido de la enfermedad y la disponibilidad de más alternativas. métodos de tratamiento más eficaces. El factor limitante de la investigación fue el hecho de que se trataba de datos de registros médicos, no había patrón de registros y, en algunos, la escasez de información.Objetivo: Avaliar a evolução clínica de pacientes com Tuberculose Resistente a Múltiplos Medicamentos atendidos em um centro de referência na região Amazônica, entre os anos de 2010 a 2014. Métodos: Pesquisa transversal, descritiva e de abordagem quantitativa, através do levantamento de dados de pacientes atendidos no Hospital Universitário de Belém do Pará,entre os anos de 2010 e 2014. Resultados: Houve a predominância do sexo masculino e a faixa etária mais acometida foi a que está na fase mais produtiva (18 a 55 anos), a forma secundária da doença esteve presente em 94,1% dos casos, o tempo de diagnóstico e o início do tratamento de 1 a 10 dias apresentou-se na maioria, quanto ao perfil de resistências às drogas que prevaleceram foram a rifampicina, isoniazida e a estreptomicina e a comorbidades mais associada foi o diabetes. Conclusão: Existe uma grande complexidade envolvendo os aspectos relacionados ao tratamento de Tuberculose Resistente a Múltiplos Medicamentos, e que estes fatores contribuem para a manutenção dos altos índices da doença, como a escassez de tecnologias como o diagnóstico rápido da doença e a disponibilidade de mais alternativas de tratamento mais eficazes. O fator limitante da pesquisa se deu ao fato de se tratar de dados de prontuários, não houve um padrão de registros e em alguns, a escassez de informações.Research, Society and Development2020-09-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/861510.33448/rsd-v9i10.8615Research, Society and Development; Vol. 9 No. 10; e3609108615Research, Society and Development; Vol. 9 Núm. 10; e3609108615Research, Society and Development; v. 9 n. 10; e36091086152525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/8615/7691Copyright (c) 2020 Paula Sousa da Silva Rocha; Dayara de Nazaré Rosa de Carvalho; Dandara de Fátima Ribeiro Bendelaque; Felipe Costa Soares; Rafael Everton Assunção Ribeiro da Costa; Marcela Raíssa Asevedo Dergan; Rogéria de Sousa Rodrigues; Jucilene Luz Neves; Ana Carolina Marinho Pinheiro; Thais Neves de Souza; Susi dos Santos Barreto de Souza; Kathleen Heloisa Pinheiro Costa Neves; Ivonete Vieira Pereira Peixoto; Armando Sequeira Penela; Marcieni Ataíde Andrade; Marcos Valério Santos da Silvahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessRocha, Paula Sousa da Silva Carvalho, Dayara de Nazaré Rosa de Bendelaque, Dandara de Fátima Ribeiro Soares, Felipe CostaCosta, Rafael Everton Assunção Ribeiro da Dergan, Marcela Raíssa Asevedo Rodrigues, Rogéria de Sousa Neves, Jucilene Luz Pinheiro, Ana Carolina Marinho Souza, Thais Neves de Souza, Susi dos Santos Barreto deNeves, Kathleen Heloisa Pinheiro Costa Peixoto, Ivonete Vieira Pereira Penela, Armando SequeiraAndrade, Marcieni Ataíde Silva, Marcos Valério Santos da 2020-10-31T12:03:23Zoai:ojs.pkp.sfu.ca:article/8615Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:31:03.236999Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Evaluation of the clinical evolution of patients with Multidrug Resistant Tuberculosis
Evaluación de la evolución clínica de los pacientes con Tuberculosis Multirresistente
Avaliação da evolução clínica de pacientes portadores de Tuberculose Resistente a Múltiplos Medicamentos
title Evaluation of the clinical evolution of patients with Multidrug Resistant Tuberculosis
spellingShingle Evaluation of the clinical evolution of patients with Multidrug Resistant Tuberculosis
Rocha, Paula Sousa da Silva
Multidrug resistant tuberculosis
Public health
Amazon.
Tuberculosis multirresistente resistente
Salud pública
Amazonas.
Tuberculose resistente a múltiplos medicamentos
Saúde pública
Amazônia.
title_short Evaluation of the clinical evolution of patients with Multidrug Resistant Tuberculosis
title_full Evaluation of the clinical evolution of patients with Multidrug Resistant Tuberculosis
title_fullStr Evaluation of the clinical evolution of patients with Multidrug Resistant Tuberculosis
title_full_unstemmed Evaluation of the clinical evolution of patients with Multidrug Resistant Tuberculosis
title_sort Evaluation of the clinical evolution of patients with Multidrug Resistant Tuberculosis
author Rocha, Paula Sousa da Silva
author_facet Rocha, Paula Sousa da Silva
Carvalho, Dayara de Nazaré Rosa de
Bendelaque, Dandara de Fátima Ribeiro
Soares, Felipe Costa
Costa, Rafael Everton Assunção Ribeiro da
Dergan, Marcela Raíssa Asevedo
Rodrigues, Rogéria de Sousa
Neves, Jucilene Luz
Pinheiro, Ana Carolina Marinho
Souza, Thais Neves de
Souza, Susi dos Santos Barreto de
Neves, Kathleen Heloisa Pinheiro Costa
Peixoto, Ivonete Vieira Pereira
Penela, Armando Sequeira
Andrade, Marcieni Ataíde
Silva, Marcos Valério Santos da
author_role author
author2 Carvalho, Dayara de Nazaré Rosa de
Bendelaque, Dandara de Fátima Ribeiro
Soares, Felipe Costa
Costa, Rafael Everton Assunção Ribeiro da
Dergan, Marcela Raíssa Asevedo
Rodrigues, Rogéria de Sousa
Neves, Jucilene Luz
Pinheiro, Ana Carolina Marinho
Souza, Thais Neves de
Souza, Susi dos Santos Barreto de
Neves, Kathleen Heloisa Pinheiro Costa
Peixoto, Ivonete Vieira Pereira
Penela, Armando Sequeira
Andrade, Marcieni Ataíde
Silva, Marcos Valério Santos da
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Rocha, Paula Sousa da Silva
Carvalho, Dayara de Nazaré Rosa de
Bendelaque, Dandara de Fátima Ribeiro
Soares, Felipe Costa
Costa, Rafael Everton Assunção Ribeiro da
Dergan, Marcela Raíssa Asevedo
Rodrigues, Rogéria de Sousa
Neves, Jucilene Luz
Pinheiro, Ana Carolina Marinho
Souza, Thais Neves de
Souza, Susi dos Santos Barreto de
Neves, Kathleen Heloisa Pinheiro Costa
Peixoto, Ivonete Vieira Pereira
Penela, Armando Sequeira
Andrade, Marcieni Ataíde
Silva, Marcos Valério Santos da
dc.subject.por.fl_str_mv Multidrug resistant tuberculosis
Public health
Amazon.
Tuberculosis multirresistente resistente
Salud pública
Amazonas.
Tuberculose resistente a múltiplos medicamentos
Saúde pública
Amazônia.
topic Multidrug resistant tuberculosis
Public health
Amazon.
Tuberculosis multirresistente resistente
Salud pública
Amazonas.
Tuberculose resistente a múltiplos medicamentos
Saúde pública
Amazônia.
description Objective: To assess the clinical evolution of patients with Multiple Drug-Resistant Tuberculosis treated in a referral center in the Amazon region, between the years 2010 to 2014. Methods: Cross-sectional, descriptive and quantitative approach research, through the collection of patient data attended at Hospital Universitário de Belém do Pará, between the years 2010 and 2014. Results: There was a predominance of males and a faixa age most affected was in the most productive phase (18 to 55 years old), secondary to teaching 94.1% were present in two cases, or time of diagnosis and initiation of treatment from 1 to 10 days appeared in the majority, how many years profile of drug resistance prevailing with rifampicin, isoniazid and streptomycin and most associated comorbidities foi or diabetes. Conclusion: There is a great complexity surrounding the aspects related to the treatment of Tuberculous Resistant to Multiple Medications, and that these factors contribute to the maintenance of two high teaching indices, as well as a scarcity of technologies such as rapid diagnosis of the teaching and availability of more alternatives of most effective treatment. The limiting factor of the investigation is due to the fact that it is a matter of medical records, there is no pattern of records in some, with little information.
publishDate 2020
dc.date.none.fl_str_mv 2020-09-30
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/8615
10.33448/rsd-v9i10.8615
url https://rsdjournal.org/index.php/rsd/article/view/8615
identifier_str_mv 10.33448/rsd-v9i10.8615
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/8615/7691
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 9 No. 10; e3609108615
Research, Society and Development; Vol. 9 Núm. 10; e3609108615
Research, Society and Development; v. 9 n. 10; e3609108615
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052803824222208